Recurrent Astrocytoma, IDH-Mutant, Grade 3
2 clinical trials · Condition
◉ Watch Recurrent Astrocytoma, IDH-Mutant, Grade 3
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma (NCT06860594) | National Cancer Institute (NCI) | 2025-07-30 |
| Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma (NCT06815029) | City of Hope Medical Center | 2025-06-17 |
Track Recurrent Astrocytoma, IDH-Mutant, Grade 3 automatically
Every clearance here is in the API, with alerts when new ones post.